These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25815140)

  • 21. Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.
    Zhang X; Wu J; Liu W; Liu Y; Xie Y; Shang Q; Zhou Z; Xu W; Tang L; Wang J; Zhao G
    Med Chem; 2017; 13(3):260-281. PubMed ID: 27633583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total purine and purine base content of common foodstuffs for facilitating nutritional therapy for gout and hyperuricemia.
    Kaneko K; Aoyagi Y; Fukuuchi T; Inazawa K; Yamaoka N
    Biol Pharm Bull; 2014; 37(5):709-21. PubMed ID: 24553148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uridine binding and transportability determinants of human concentrative nucleoside transporters.
    Zhang J; Smith KM; Tackaberry T; Visser F; Robins MJ; Nielsen LP; Nowak I; Karpinski E; Baldwin SA; Young JD; Cass CE
    Mol Pharmacol; 2005 Sep; 68(3):830-9. PubMed ID: 15955867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.
    Toan SV; To KK; Leung GP; de Souza MO; Ward JL; Tse CM
    Pflugers Arch; 2003 Nov; 447(2):195-204. PubMed ID: 14504928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug-Drug Interactions.
    Mandíková J; Volková M; Pávek P; Navrátilová L; Hyršová L; Janeba Z; Pavlík J; Bárta P; Trejtnar F
    Front Pharmacol; 2015; 6():304. PubMed ID: 26779022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Link between high-affinity adenosine concentrative nucleoside transporter-2 (CNT2) and energy metabolism in intestinal and liver parenchymal cells.
    Huber-Ruano I; Pinilla-Macua I; Torres G; Casado FJ; Pastor-Anglada M
    J Cell Physiol; 2010 Nov; 225(2):620-30. PubMed ID: 20506327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
    Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
    Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel purine nucleoside derivatives as phosphodiesterase 2 (PDE2) inhibitors: Structure-based virtual screening, optimization and biological evaluation.
    Qiu X; Huang Y; Wu D; Mao F; Zhu J; Yan W; Luo HB; Li J
    Bioorg Med Chem; 2018 Jan; 26(1):119-133. PubMed ID: 29174506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line.
    Crawford CR; Cass CE; Young JD; Belt JA
    Biochem Cell Biol; 1998; 76(5):843-51. PubMed ID: 10353719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel C2-purine position analogs of nitrobenzylmercaptopurine riboside as human equilibrative nucleoside transporter 1 inhibitors.
    Gupte A; Buolamwini JK
    Bioorg Med Chem; 2007 Dec; 15(24):7726-37. PubMed ID: 17881236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food.
    Mahor D; Priyanka A; Prasad GS; Thakur KG
    PLoS One; 2016; 11(10):e0164279. PubMed ID: 27768715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 6-aryloxy- and 6-arylalkoxy-2-chloropurines and their interactions with purine nucleoside phosphorylase from Escherichia coli.
    Bzowska A; Magnowska L; Kazimierczuk Z
    Z Naturforsch C J Biosci; 1999 Dec; 54(12):1055-67. PubMed ID: 10685497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of a potent and selective inhibitor of human urate transporter 1.
    Wu T; Chen J; Dong S; Li H; Cao Y; Tian Y; Fu W; Zhou P; Xi B; Pang J
    Pharmacol Rep; 2017 Oct; 69(5):1103-1112. PubMed ID: 28988709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.
    Ghoteimi R; Nguyen VT; Rahimova R; Grosjean F; Cros-Perrial E; Uttaro JP; Mathé C; Chaloin L; Jordheim LP; Peyrottes S
    ChemMedChem; 2019 Aug; 14(15):1431-1443. PubMed ID: 31264794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system.
    Schaner ME; Wang J; Zhang L; Su SF; Gerstin KM; Giacomini KM
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1487-91. PubMed ID: 10336543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific mutations in transmembrane helix 8 of human concentrative Na+/nucleoside cotransporter hCNT1 affect permeant selectivity and cation coupling.
    Slugoski MD; Loewen SK; Ng AM; Smith KM; Yao SY; Karpinski E; Cass CE; Baldwin SA; Young JD
    Biochemistry; 2007 Feb; 46(6):1684-93. PubMed ID: 17279631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.
    Yamamoto T; Kuniki K; Takekuma Y; Hirano T; Iseki K; Sugawara M
    Eur J Pharmacol; 2007 Feb; 557(1):1-8. PubMed ID: 17140564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the molecular biology of nucleoside transporters of mammalian cells.
    Cass CE; Young JD; Baldwin SA
    Biochem Cell Biol; 1998; 76(5):761-70. PubMed ID: 10353709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.
    Pastor-Anglada M; Pérez-Torras S
    Front Pharmacol; 2015; 6():13. PubMed ID: 25713533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
    Torralba KD; De Jesus E; Rachabattula S
    Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.